Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor
Cell Line, Tumor
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Enzyme Inhibitors
/ chemical synthesis
Humans
Indoles
/ chemical synthesis
Models, Molecular
Molecular Structure
Phosphoglycerate Dehydrogenase
/ antagonists & inhibitors
Serine
/ antagonists & inhibitors
Structure-Activity Relationship
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
12 09 2019
12 09 2019
Historique:
pubmed:
1
8
2019
medline:
1
7
2020
entrez:
1
8
2019
Statut:
ppublish
Résumé
Phosphoglycerate dehydrogenase (PHGDH) is known to be the rate-limiting enzyme in the serine synthesis pathway in humans. It converts glycolysis-derived 3-phosphoglycerate to 3-phosphopyruvate in a co-factor-dependent oxidation reaction. Herein, we report the discovery of
Identifiants
pubmed: 31365252
doi: 10.1021/acs.jmedchem.9b00718
doi:
Substances chimiques
Enzyme Inhibitors
0
Indoles
0
Serine
452VLY9402
Phosphoglycerate Dehydrogenase
EC 1.1.1.95
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM